Global Erectile Dysfunction Drugs Market 2014-2018 is the latest addition to Sandlerresearch.org industry research reports collection.
One of the emerging trends in this market is an increase in awareness of erectile dysfunction. The acceptability of erectile dysfunction drugs is expected to increase owing to increasing public awareness about erectile dysfunction and the need to treat it.
The Report recognizes the following companies as the key players in the Global Erectile Dysfunction Drugs Market: Apricus Biosciences Inc., Bayer AG, Dong-A Socio Holdings Co. Ltd., Eli Lily & Co., Pfizer Inc. and Vivus Inc.
Other Prominent Vendors in the market are: Auxillium Pharmaceuticals, Cristalia Produtos Quimicos Farmaceuticos, Futura Medical, Johnson & Johnson, Meda Pharmaceuticals, Pacific Therapeutics and Seattle Genetics.
Order a copy of this report at (Prices start at US $2500 for a single user PDF) http://www.sandlerresearch.org/purchase?rname=23077 .
According to the report, one of the main drivers in the market is the increase in aging population. The number of patients suffering from erectile dysfunction is growing owing to increasing aging population both in developing and developed countries.
Further, the report states that one of the main challenges in the market is the high cost of erectile dysfunction drugs. Despite numerous benefits, the high cost of erectile dysfunction drugs hinders acceptability among patients. Many patients do not have the required budget for investing in high-cost treatment options.
Table of Contents· Executive Summary
· List of Abbreviations
· Scope of the Report
· Market Research Methodology
· Market Landscape
· Market Segmentation by Treatment
· Market Assessment of Top Drugs
· Competitive Assessment of Top Drugs
· Geographical Segmentation
· Buying Criteria
· Rate of Incidence and Prevalence
· Market Growth Drivers
· Drivers and their Impact
· Market Challenges
· Impact of Drivers and Challenges
· Market Trends
· Trends and their Impact
· Vendor Landscape
· Key Vendor Analysis
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Erectile Dysfunction Drugs Market 2013-2018 (US$ billion)
Exhibit 3: Global Erectile Dysfunction Drugs Market Segmentation by Treatment
Exhibit 4: Pfizer's Viagra Revenue 2010-2013 (US$ million)
Exhibit 5: Eli Lily's Cialis Revenue 2010-2013 (US$ million)
Exhibit 6: Bayer's Levitra Revenue 2010-2013 (US$ million)
Exhibit 7: Sales of Top 3 Erectile Dysfunction Drugs FY 2010-2013 (US$ million)
Exhibit 8: Sales of Top 3 Erectile Dysfunction Drugs FY 20010-2013 (US$ million)
Exhibit 9: Global Erectile Dysfunction Drugs Market by Geographical Segmentation 2013
Exhibit 11: Apricus Biosciences: Geographical Segmentation by Revenue 2013
Exhibit 12: Business Segmentation of Bayer AG 2013
Exhibit 13: Sales Comparison of Bayer AG by Business Segment 2012 and 2013 (US$ million)
Exhibit 14: Sales Segmentation of Bayer AG by Geography 2013
Exhibit 15: Dong-A Socio: Business Segmentation 2013
Exhibit 16: Dong-A Socio: Geographical Segmentation by Revenue 2013
Exhibit 17: Eli Lilly and Co.: Business Segmentation by Revenue 2013
Exhibit 18: Eli Lilly and Co.: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 19: Eli Lilly and Co.: Sales by Geography 2013
Exhibit 20: Pfizer Inc.: Business Segmentation